Lineage Cell Therapeutics (LCTX) Long-Term Investments (2015 - 2019)
Lineage Cell Therapeutics (LCTX) posted Long-Term Investments of $36.54 million for Q2 2019, down 45.3% from $66.78 million a year earlier and down 37.0% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Long-Term Investments (2015 - 2019) Analysis & Trends
At the end of FY2018, Lineage Cell Therapeutics' Long-Term Investments came in at $33.73 million, down 71.2% from FY2017.
- Annual Long-Term Investments shows a three-year compound annual growth rate of 93.3% (FY2015 to FY2018).
- In prior years, Lineage Cell Therapeutics' Long-Term Investments was $117.17 million in FY2017 and $4.67 million in FY2015.
- Quarterly Long-Term Investments has run from a low of $3.48 million in Q3 2016 to a high of $184.73 million in Q3 2017 over five years.
- On a year-over-year basis, Long-Term Investments has declined in each of the last six quarters, with an average decline of 41.7% over the last six quarters.
- According to Business Quant data, Long-Term Investments for the three prior quarters was $57.96 million (Q1 2019), $33.73 million (Q4 2018) and $108.21 million (Q3 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 36.54 Mn |
| Mar 31, 2019 | 57.96 Mn |
| Dec 31, 2018 | 33.73 Mn |
| Sep 30, 2018 | 108.21 Mn |
| Jun 30, 2018 | 66.78 Mn |
| Mar 31, 2018 | 62.35 Mn |
| Dec 31, 2017 | 117.17 Mn |
| Sep 30, 2017 | 184.73 Mn |
| Jun 30, 2017 | 153.51 Mn |
| Mar 31, 2017 | 87.31 Mn |
| Sep 30, 2016 | 3.48 Mn |
| Jun 30, 2016 | 4.34 Mn |
| Mar 31, 2016 | 4.44 Mn |
| Dec 31, 2015 | 4.67 Mn |
API Access
Lineage Cell Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();